Wuhan Ammunition Life-tech Co., Ltd.
PrivateLast Round
Series C
Apr 28, 2022
Est. Valuation
$182.93M
Total Funding Raised
$36.95M
Company Overview
Wuhan Ammunition Life-tech Co., Ltd. operates in Healthcare & Life Sciences and is based in Wuhan. Its latest recorded funding round was a Series C round in April 2022.
Wuhan Ammunition Life-tech Co., Ltd. is a biotechnology company that specializes in the research, development, production, and sale of non-invasive early cancer detection products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wuhan Ammunition Life-tech Co., Ltd. Comparables
Compare Wuhan Ammunition Life-tech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creative Biosciences (Guangzhou) Co., Ltd. | 87% | |
| New Horizon Health | 79% | |
| Kindstar Global | 79% |
For institutional investors. Book with your work email.
Wuhan Ammunition Life-tech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 28, 2022 | ||||
| Series B | Feb 3, 2021 | ||||
| Series A | Apr 27, 2020 | ||||
| Early Funding | Jan 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wuhan Ammunition Life-tech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CCB International | Series C |
| Wuhan Gaoke State-owned Holding Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2022
$15.1M round led by CCB International
- Apr 27, 2020
$4.24M round led by CCB Medical Growth Fund.
For institutional investors. Book with your work email.
Wuhan Ammunition Life-tech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wuhan Ammunition Life-tech Co., Ltd.'s valuation, stock price, and market status.
Is Wuhan Ammunition Life-tech Co., Ltd. a public or private company?
Wuhan Ammunition Life-tech Co., Ltd. is a private company.
What is the current stock price of Wuhan Ammunition Life-tech Co., Ltd.?
Wuhan Ammunition Life-tech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Wuhan Ammunition Life-tech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wuhan Ammunition Life-tech Co., Ltd. worth (valuation)?
Wuhan Ammunition Life-tech Co., Ltd.'s valuation is estimated at $182.9M based on funding round data.
Can I buy Wuhan Ammunition Life-tech Co., Ltd. stock?
Wuhan Ammunition Life-tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wuhan Ammunition Life-tech Co., Ltd.'s last funding round?
Wuhan Ammunition Life-tech Co., Ltd.'s most recent funding round was Series C on April 28, 2022.
Who are the main investors in Wuhan Ammunition Life-tech Co., Ltd.?
Key investors in Wuhan Ammunition Life-tech Co., Ltd. include CCB International.
Will Wuhan Ammunition Life-tech Co., Ltd. IPO soon?
No public IPO plans have been announced for Wuhan Ammunition Life-tech Co., Ltd..
How can I track Wuhan Ammunition Life-tech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Wuhan Ammunition Life-tech Co., Ltd.'s shares on secondary markets.